IRIS
MAZZUCCHELLI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.279
EU - Europa 6.048
AS - Asia 6.002
SA - Sud America 1.431
AF - Africa 285
Continente sconosciuto - Info sul continente non disponibili 284
OC - Oceania 15
AN - Antartide 1
Totale 27.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.953
SG - Singapore 1.845
VN - Vietnam 1.174
BR - Brasile 1.135
RU - Federazione Russa 1.059
UA - Ucraina 1.018
CN - Cina 882
IT - Italia 751
DE - Germania 615
HK - Hong Kong 597
IE - Irlanda 569
TR - Turchia 554
SE - Svezia 521
DK - Danimarca 387
FR - Francia 377
FI - Finlandia 310
GB - Regno Unito 223
KR - Corea 223
CA - Canada 161
IN - India 154
BD - Bangladesh 100
AR - Argentina 98
MX - Messico 97
CI - Costa d'Avorio 89
IQ - Iraq 73
ID - Indonesia 63
ZA - Sudafrica 58
EC - Ecuador 57
JP - Giappone 56
MA - Marocco 41
CO - Colombia 39
PK - Pakistan 39
BE - Belgio 32
NL - Olanda 31
PL - Polonia 31
ES - Italia 28
SA - Arabia Saudita 27
VE - Venezuela 27
UZ - Uzbekistan 25
IR - Iran 24
EG - Egitto 22
PH - Filippine 21
CL - Cile 20
MY - Malesia 20
PE - Perù 20
RO - Romania 20
PY - Paraguay 18
EU - Europa 17
JO - Giordania 17
TH - Thailandia 16
TW - Taiwan 15
AT - Austria 14
CR - Costa Rica 14
DZ - Algeria 14
KE - Kenya 14
KZ - Kazakistan 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
AU - Australia 9
HN - Honduras 9
PT - Portogallo 9
UY - Uruguay 9
ET - Etiopia 8
AL - Albania 7
AZ - Azerbaigian 7
CH - Svizzera 7
GR - Grecia 7
LB - Libano 7
OM - Oman 7
SV - El Salvador 7
BH - Bahrain 6
HU - Ungheria 6
KG - Kirghizistan 6
NP - Nepal 6
NZ - Nuova Zelanda 6
BO - Bolivia 5
NG - Nigeria 5
PA - Panama 5
AO - Angola 4
CZ - Repubblica Ceca 4
LT - Lituania 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BB - Barbados 3
GT - Guatemala 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
GY - Guiana 2
MM - Myanmar 2
MU - Mauritius 2
NI - Nicaragua 2
Totale 27.045
Salva come PNG Salva come JPEG
Città #
Ashburn 1.885
Singapore 1.202
Jacksonville 1.030
Chandler 976
Fairfield 758
Dallas 708
Des Moines 580
Boardman 569
Hong Kong 569
Dublin 568
Council Bluffs 533
San Jose 516
Wilmington 402
New York 392
Ho Chi Minh City 389
Woodbridge 332
Houston 283
Seattle 278
Hanoi 252
The Dalles 234
Beijing 229
Princeton 226
Lawrence 224
San Mateo 215
Cambridge 214
Lauterbourg 210
Ann Arbor 192
Moscow 154
Los Angeles 142
Centro 135
Hefei 134
São Paulo 98
San Diego 92
Milan 90
Abidjan 89
Munich 87
Buffalo 77
Helsinki 73
Chicago 72
Santa Clara 68
Haiphong 65
Da Nang 61
London 51
Vancouver 48
Tokyo 44
Redmond 42
Shanghai 39
Turku 39
Frankfurt am Main 37
Mexico City 36
Phoenix 36
Baghdad 34
Orem 34
Rio de Janeiro 34
Washington 32
Brussels 31
Guangzhou 31
Miano 31
Wuhan 30
Rome 29
Pune 28
Warsaw 28
Ancona 27
Belo Horizonte 27
Chennai 27
Brooklyn 24
Marche 24
Montreal 24
San Francisco 24
Biên Hòa 23
Denver 23
Tashkent 22
Atlanta 21
Columbus 21
Izmir 21
Turin 21
Manchester 20
Hải Dương 19
Curitiba 18
Erbil 18
Guayaquil 18
Durban 17
Istanbul 17
Porto 17
Quito 17
Salvador 17
Johannesburg 16
Stockholm 16
Toronto 16
Amman 15
Salt Lake City 15
Brasília 14
Campinas 14
Elk Grove Village 14
Norwalk 14
Porto Alegre 14
Jiaxing 13
Amsterdam 12
Boston 12
Brasov 12
Totale 16.821
Salva come PNG Salva come JPEG
Nome #
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer 436
Metabolic phenotype of bladder cancer 268
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 221
AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia 211
The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer 206
Predicting future cancer burden in the United States by artificial neural networks 201
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learned 192
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 188
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 187
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 180
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 176
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 171
Secondary neoplasms of the urinary system and male genital organs. 170
[Interstitial cystitis: minimal diagnostic criteria]. 163
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 162
[Thin glomerular basement membrane disease]. 162
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 161
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 161
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 160
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 158
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 157
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Metabolic Alterations in Renal and Prostate Cancer 155
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 155
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 153
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 153
Active surveillance for low-risk prostate cancer. 152
Analytical and Qualitative Cytology and Histology. Reflection on the past two years. 150
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 148
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 148
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 148
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? 148
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 147
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 147
2005 update on pathology of prostate biopsies with cancer 146
Angiogenesis as prognostic factor in small renal tumors 145
Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancer 145
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 144
Genitourinary cancers: molecular determinants for personalized therapies 143
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study 142
A contemporary update on pathology reporting for urinary bladder cancer. 141
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 141
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 141
Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis 141
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 140
Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma 139
[Nephrotic proteinuria with type 2 diabetes mellitus and autoimmune thyroiditis]. 139
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT 138
Adipose cannabinoid CBI receptor and adiponectin expression correlate with microvascular damage in human-kidney 138
Ciliary Neurotrophic Factor Modulates Multiple Downstream Signaling Pathways in Prostate Cancer Inhibiting Cell Invasiveness 138
Morphological diagnosis of urothelial neoplasms. 137
Epigenetic modifications and modulators in prostate cancer 136
A painful diagnosis 135
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 134
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 133
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 133
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 132
Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line 131
PUNLMP or not PUNLMP? This is the problem. 131
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 131
Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. 130
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 130
pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging 130
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. 129
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 128
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. 128
Increased VEGF165 expression in HCT116 colon cancer cells after transient transfection with a GFP vector encoding HIF-1 gene. 127
Renal sarcoma associated with adult polycystic kidney disease. A case report and literature review. 126
Changes in the normal-looking epithelium in prostates with PIN or cancer. 126
alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer 126
Pathology and molecular updates in tumors of the prostate: towards a personalized approach. 126
Biphasic Tumors of the Urogenital Tract: Selected Topics 125
A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomy 122
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 122
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 122
Immunohistochemical expression of Endothelin-1 and Endothelin-A and Endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. 120
Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides 120
Pathology of prostate cancer and focal therapy ('male lumpectomy'). 119
KIDNEY CANCER: NOT A SINGLE DISEASE. 119
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 119
Molecular techniques and prostate cancer diagnostic. 119
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 119
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections. 118
Urothelial changes induced by therapeutic procedures for bladder cancer. A review. 117
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 117
Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes 117
Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy. 117
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. 117
Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens. 116
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. 116
Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? 116
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy. 116
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 115
Preneoplastic lesions of the prostate. 115
Case diagnosis as positive identification in prostatic neoplasia 115
Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation 115
Molecular mechanisms in prostate cancer. A review. 114
[Diagnosis of Alport syndrome] 114
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients 114
NRF2 modulation in TRAMP mice: an in vivo model of prostate cancer 113
Totale 14.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.152 0 0 55 93 11 109 47 108 106 132 107 384
2022/20233.227 282 248 202 277 224 840 8 202 738 17 125 64
2023/20241.857 312 56 90 268 317 427 26 41 13 44 31 232
2024/20253.689 389 311 190 89 116 109 350 176 925 257 352 425
2025/20269.537 530 704 752 1.023 855 663 1.824 955 805 790 207 429
2026/20271.051 426 439 186 0 0 0 0 0 0 0 0 0
Totale 27.345